[1]
“Cutaneous Manifestations of IBD: Potential Role of Vedolizumab”, Can Dermatol Today, vol. 5, no. 1, pp. 19–27, Mar. 2024, Accessed: Sep. 17, 2026. [Online]. Available: https://canadiandermatologytoday.com/article/view/5-1-Lipson